CSIMarket

Stericycle Inc   (SRCL)
Other Ticker:  
 
    Sector  Services    Industry Environmental Services
   Industry Environmental Services
   Sector  Services
 
Price: $48.6800 $0.08 0.165%
Day's High: $49.44 Week Perf: 2.53 %
Day's Low: $ 48.78 30 Day Perf: -8.86 %
Volume (M): 7 52 Wk High: $ 79.94
Volume (M$): $ 318 52 Wk Avg: $62.90
Open: $47.87 52 Wk Low: $44.04



 Market Capitalization (Millions $) 4,479
 Shares Outstanding (Millions) 92
 Employees 16,718
 Revenues (TTM) (Millions $) 2,643
 Net Income (TTM) (Millions $) -67
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) 130

Stericycle Inc

We were incorporated in 1989 and presently serve approximately 394,600 customers throughout the United States, United Kingdom, Mexico, Canada, Ireland, Argentina and Puerto Rico.

In North America we have a fully integrated, national network that includes 53 processing centers and 93 additional transfer and collection sites. We use this network to provide a broad range of services to our customers related to medical waste management services and regulated return management services. Regulated medical waste management services include servicing a variety of customers to remove and process waste while regulated return management services are physical services provided to companies and individual businesses that assist with the handling of products that are being removed from the supply chain due to recalls and expiration. These services also included advanced notification technology that is used to communicate specific instructions to the users of the product. Our waste treatment technologies include autoclaving, incineration, chemical treatment and our proprietary electro-thermal-deactivation system.

We are in the business of managing regulated waste and providing an array of related services. We operate in the United States, Canada, Mexico, the United Kingdom, Ireland and Argentina.

For large-quantity generators of regulated waste such as hospitals and for pharmaceutical companies and distributors, we offer:

• our institutional regulated waste management services

• our Bio Systems® sharps management services to reduce the risk of needle sticks

• a variety of products and services for infection control

• our regulated returns management services for expired or recalled healthcare products

For small-quantity generators of regulated waste such as doctors’ offices and for retail pharmacies, we offer:

• our regulated waste management services

• our Steri-Safe® Occupational Safety and Health Act and Health Insurance Portability and Accountability Act (“HIPAA”) compliance programs

• a variety of products and services for infection control

• our regulated returns management services for expired or recalled healthcare products

Our regulated waste processing technologies include autoclaving, our proprietary electro-thermal-deactivation system (“ETD”), chemical treatment and incineration.

Competition

The regulated waste industry is highly competitive, and barriers to entry into the regulated waste collection and disposal business and the pharmaceutical returns business are very low. Our competitors consist of many different types of service providers, including a large number of regional and local companies. In the regulated waste industry, another major source of competition is the on-site treatment of regulated waste by some large-quantity generators, particularly hospitals.

In addition, in the regulated waste industry we face potential competition from businesses that are attempting to commercialize alternate treatment technologies or products designed to reduce or eliminate the generation of regulated waste, such as reusable or degradable medical products.



   Company Address: 2355 Waukegan Road Bannockburn 60015 IL
   Company Phone Number: 367-5910   Stock Exchange / Ticker: NASDAQ SRCL
   SRCL is expected to report next financial results on August 05, 2022.


Customers Net Income grew by SRCL's Customers Net Profit Margin fell to

17.52 %

25 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
RSG   -3.29%    
WM   -4.09%    
• View Complete Report
   



The Glimpse Group Inc.

The Glimpse Group Inc reported fiscal span ending Mar 31 2022 operating deficit of $-2.376502 millions

The Glimpse Group Inc reported disappointing fiscal span ending Mar 31 2022, where Sales melted down by -40.02% to $2.05 millions and company posted loss per share to $-0.14, compared to $-0.84, in the same quarter a year ago.

Adhera Therapeutics Inc.

Redemption of Losses by Adhera Therapeutics Inc in the fiscal first quarter of 2022 statement

In the fiscal first quarter of 2022 Adhera Therapeutics Inc decreased loss of $-0.03 per share compared to $-0.84 a year ago and improved from $-0.32 per share from the previous quarter.

Isun Inc.

Isun Inc declared first quarter of 2022 operating loss of $-5.703 millions

Isun Inc announced very strong Sales growth of 107.79% year on year to $15.09 millions in the first quarter of 2022, but lost money at $-0.23.

Flexible Solutions International Inc.

Robust Top-line rise at Flexible Solutions International Inc in the most recent fiscal period

In the most recent fiscal period Flexible Solutions International Inc eps remained unchanged of $0.12 per share compared to $0.12 a year ago and EPS turn positive from $-0.03 per share from the previous quarter.

Invo Bioscience Inc.

Invo Bioscience Inc announced fiscal first quarter of 2022 operating loss of $-2.700938 millions

In the fiscal first quarter of 2022 Invo Bioscience Inc lost money of $-0.23 per share compared to $-0.63 a year ago and eps fell from $0.37 per share from the previous quarter.






 

Stericycle Inc 's Segments
 
Regulated medical waste management
 Segment    95.79 % of total Revenue
Regulated returns management services
 Segment    4.21 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Stericycle Inc does not provide revenue guidance.

Earnings Outlook
Invo Bioscience Inc. does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 70.31 %
Europe 15.93 %
Other Foreign Countries 13.76 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GTPB's Profile

Stock Price

GTPB's Financials

Business Description

Fundamentals

Charts & Quotes

GTPB's News

Suppliers

GTPB's Competitors

Customers & Markets

Economic Indicators

GTPB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071